Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0F6KM
|
||||
| Former ID |
DCL001199
|
||||
| Drug Name |
ISIS-APOCIII
|
||||
| Drug Type |
Antisense drug
|
||||
| Indication | Inflammation; High triglycerides; Atherosclerosis; Metabolic syndrome [ICD9: 277.7, 414.0, 440; ICD10:E88.81, I70] | Phase 1 | [551052] | ||
| Company |
ISIS Pharm
|
||||
| Target and Pathway | |||||
| Target(s) | mRNA of ApoC-III | Target Info | [551052] | ||
| KEGG Pathway | PPAR signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.